KiOmed Pharma offers a unique pipeline of products to tackle invalidating OsteoArthritis, Skin Aging and Dry Eye syndrome.
KiOmed Pharma has raised $19.5M in total funding. The most recent round was Undisclosed. The last funding was announced in March 2025.
KiOmed Pharma is headquartered in Herstal, Belgium.
KiOmed Pharma offers a unique pipeline of products to tackle invalidating OsteoArthritis, Skin Aging and Dry Eye syndrome.
KiOmed Pharma is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"KiOmed Pharma — Funding & Investors." VCBacked, March 31, 2025, https://www.vcbacked.co/company/kiomed-pharma. Accessed October 6, 2026.
VCBacked. (2025). KiOmed Pharma — Funding & Investors. Retrieved October 6, 2026, from https://www.vcbacked.co/company/kiomed-pharma
{{cite web |title=KiOmed Pharma — Funding & Investors |url=https://www.vcbacked.co/company/kiomed-pharma |website=VCBacked |access-date=October 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated